BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.00925
0.00 (0.00%)
Jun 3, 2026, 4:00 PM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $8.99 million as of June 4, 2026. Its market cap has decreased by -59.15% in one year.
Market Cap
8.99M
Enterprise Value
11.11M
Revenue
1.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 8.99M, a decrease of -81.99%. That is a compound annual growth rate of -53.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 8.99M | -27.58% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CareView Communications | 32.11M |
| Retrieve Medical Holdings | 25.67M |
| Veri Medtech Holdings | 23.75M |
| Pharma-Bio Serv | 12.94M |
| PreAxia Health Care Payment Systems | 9.47M |
| CompuMed | 8.98M |
| DATATRAK International | 8.50M |
| Vynleads | 7.88M |